SEATTLE, WA, Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, has announced the second closing of a $10 million oversubscribed Series A financing. more...

PLEASANTON, CA, Amador Bioscience, a global translational sciences and clinical pharmacology CRO, has raised a $60 million Series B+ financing. more...

SEATTLE, WA, Good Therapeutics has raised an $8 million Series B financing round. more...